• Citer

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

par Fabbri, Chiara;Crisafulli, Concetta;Calati, Raffaella;Albani, Diego;Forloni, GianLuigi Luigi G.;Calabrò, Marco;Martines, Rosalba;Kasper, Siegfried S.F.;Zohar, Joseph;Juven-Wetzler, Alzbeta;Souery, Daniel ;Montgomery, Stuart;Mendlewicz, Julien ;Serretti, Alessandro
Référence European archives of psychiatry and clinical neuroscience, 267, 8, page (723-735)
Publication Publié, 2017-12

Article révisé par les pairs

• Détails
• Contenu

Titre:	Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Auteur:	Fabbri, Chiara; Crisafulli, Concetta; Calati, Raffaella; Albani, Diego; Forloni, GianLuigi Luigi G.; Calabrò, Marco; Martines, Rosalba; Kasper, Siegfried S.F.; Zohar, Joseph; Juven-Wetzler, Alzbeta; Souery, Daniel; Montgomery, Stuart; Mendlewicz, Julien; Serretti, Alessandro
Informations sur la publication:	European archives of psychiatry and clinical neuroscience, 267, 8, page (723-735)
Statut de publication:	Publié, 2017-12
Sujet CREF:	Psychiatrie
	Pharmacologie
	Physiopsychologie et psychologie biologique [psychiatrie]
Mots-clés:	Antidepressant
	Gene
	Neuroplasticity
	Pharmacogenetics
	Polymorphism
	Treatment-resistant depression
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0940-1334
	info:doi/10.1007/s00406-017-0766-1
	info:scp/85014203847